Prevention of Postoperative Nausea and Vomiting (PONV) by Acupressure

NCT ID: NCT00275483

Last Updated: 2008-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

132 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-05-31

Study Completion Date

2007-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether stimulation to the akupressurpoint P6 with a recently developed bracelet are effective preventing postoperative nausea and vomiting

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Nausea and Vomiting Acupressure Point P6

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vital-band (R)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female,
* Non-smoker,
* \>18 years,
* ASA 1 or 2,
* Signed patient information,
* IV-anaestesia.

Exclusion Criteria

* Male,
* Smoker,
* ASA 3 or 4,
* Pregnancy,
* Nausea and vomiting within the last 24 h before operation,
* Diabetes,
* Carpaltunnel syndrome,
* Lymphedema of arms,
* Eczema of forearm,
* Patients who earlier has undergone removal of lymph nodes in the armpits,
* Inhalation anaestesia.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Herlev Hospital

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Birgitte Majholm, MD

Role: PRINCIPAL_INVESTIGATOR

Herlev Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Herlev University Hospital, department of anaestesiology

Copenhagen, Herlev, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Vital-band 01

Identifier Type: -

Identifier Source: org_study_id